|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.99 USD | +0.97% |
|
+4.88% | -8.60% |
| 07/05 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
| 01/05 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
USANA Health Sciences, Inc. announced that Jim Brown will succeed Kevin Guest, who will transition to Executive Chairman of the Company on the effective July 1, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.60% | 933M | |
| +16.86% | 8.43B | |
| +3.57% | 7.49B | |
| +4.89% | 6.23B | |
| -5.23% | 3.75B | |
| -6.58% | 3.75B | |
| -3.55% | 1.33B | |
| -28.64% | 1.09B | |
| +18.12% | 1.02B | |
| -17.08% | 801M |
USANA HEALTH SCIENCES, INC. 
